日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ENGOT-EN20/GOG-3083/XPORT-EC-042 - A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial design

ENGOT-EN20/GOG-3083/XPORT-EC-042——一项III期、随机、安慰剂对照、双盲、多中心试验,评估塞利尼索在p53野生型、晚期或复发性子宫内膜癌患者系统治疗后维持治疗中的疗效:研究原理、方法和试验设计

Vergote, Ignace; Perez Fidalgo, Alejandro; Valabrega, Giorgio; Monk, Bradley J; Herzog, Thomas; Cibula, David; Colombo, Nicoletta; Pothuri, Bhavana; Sehouli, Jalid; Korach, Jacob; Barlin, Joyce; Papadimitriou, Christos A; van Gorp, Toon; Richardson, Debra; McCarthy, Michael; Antill, Yoland; Mirza, Mansoor Raza; Li, Kai; Kalyanapu, Pratheek; Slomovitz, Brian; Coleman, Robert L

Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study

对TP53野生型晚期或复发性子宫内膜癌患者进行塞利尼索维持治疗的疗效和安全性的长期随访:ENGOT-EN5/GOG-3055/SIENDO研究的亚组分析

Makker, Vicky; Perez-Fidalgo, Jose Alejandro; Valabrega, Giorgio; Hamilton, Erika; Van Gorp, Toon; Sehouli, Jalid; Regináčová, Klaudia; Richardson, Debra L; Perri, Tamar; Oza, Amit M; Miller, David S; Alía, Eva Maria Guerra; De Giorgi, Ugo; Henry, Stephanie; Spitz, Daniel L; Wimberger, Pauline; Bednaříková, Markéta; Chon, Hye Sook; Martínez-Garcia, Jerónimo; Pisano, Carmela; Berek, Jonathan S; Romero, Ignacio; Scambia, Giovanni; Fariñas-Madrid, Lorena; Buscema, Joseph; Schochter, Fabienne; Li, Kai; Kalyanapu, Pratheek; Walker, Christopher J; Vergote, Ignace